Vincent Aurentz

Insider Reports History

Entity
Individual
Location
C/O Arena Pharmaceuticals, Inc., 6154 Nancy Ridge Drive, San Diego, CA
Signature
/s/ Garth Lees-Rolfe, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Vincent Aurentz:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Inhibikase Therapeutics, Inc. Director Stock Option (Right to Buy) 134K Feb 21, 2025 Direct
Longboard Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 22.5K May 23, 2024 Direct
ARENA PHARMACEUTICALS INC Executive VP and CBO Common Stock 0 $98.51 Mar 11, 2022 Direct
ARENA PHARMACEUTICALS INC Executive VP and CBO Employee Performance Restricted Stock Unit 0 Mar 11, 2022 Direct
ARENA PHARMACEUTICALS INC Executive VP and CBO Employee Stock Option (right to buy) 0 Mar 11, 2022 Direct
Longboard Pharmaceuticals, Inc. Director Employee Stock Option (right to buy) 0 Dec 2, 2024 Direct

Insider Reports Filed by Vincent Aurentz

Symbol Company Period Transactions Value $ Form Type Date Filed Role
IKT Inhibikase Therapeutics, Inc. Feb 21, 2025 1 $0 4 Feb 25, 2025 Director
IKT Inhibikase Therapeutics, Inc. Feb 21, 2025 0 $0 3 Feb 25, 2025 Director
LBPH Longboard Pharmaceuticals, Inc. Dec 2, 2024 5 $0 4 Dec 2, 2024 Director
LBPH Longboard Pharmaceuticals, Inc. May 23, 2024 1 $0 4 May 24, 2024 Director
LBPH Longboard Pharmaceuticals, Inc. May 25, 2023 1 $0 4 May 26, 2023 Director
LBPH Longboard Pharmaceuticals, Inc. May 24, 2022 1 $0 4 May 31, 2022 Director
ARNA ARENA PHARMACEUTICALS INC Mar 11, 2022 10 $0 4 Mar 11, 2022 Executive VP and CBO
ARNA ARENA PHARMACEUTICALS INC Jan 3, 2022 1 $0 4 Jan 5, 2022 Executive VP and CBO
LBPH Longboard Pharmaceuticals, Inc. Sep 14, 2021 2 $0 4 Sep 14, 2021 Director